NTF4 and diabetes mellitus: In diabetes and impaired glucose metabolism, chronic hyperglycemia triggers advanced glycation end-products (AGEs) and inflammatory cytokines that reduce neurotrophic support by downregulating NT-4 and TrkB expression and altering axonal regeneration [27,28,29].